Fuai Lu
Impact in
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Systemic Lupus Erythematosus Research 4
- Rheumatoid Arthritis Research and Therapies 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Co-authors
- Yongfu Wang (2 shared papers)Yuan Liu (2 shared papers)Le Wang (1 shared paper)Yuan Liu (1 shared paper)Liu Miao (1 shared paper)Fanlei Hu (1 shared paper)Ke Li (1 shared paper)Xiaofen Li (1 shared paper)
In The Last Decade
Fuai Lu
11 papers receiving 317 citations
Fuai Lu's Hit Papers
Peers
Comparison fields: 5 of 45
- Rheumatology 88
- Pulmonary and Respiratory Medicine 111
- Nephrology 21
- Immunology 18
- Molecular Biology 39
Countries citing papers authored by Fuai Lu
This map shows the geographic impact of Fuai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuai Lu more than expected).
Fields of papers citing papers by Fuai Lu
This network shows the impact of papers produced by Fuai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuai Lu. The network helps show where Fuai Lu may publish in the future.
Co-authors
The 11 scholars most cited alongside Fuai Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 135 | |
| 2 | Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2023 | 101 |
| 3 | 2021 | 19 | |
| 4 | 2020 | 16 | |
| 5 | 2022 | 16 | |
| 6 | 2021 | 14 | |
| 7 | 2025 | 9 | |
| 8 | 2022 | 5 | |
| 9 | 2023 | 5 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 1 |
About Fuai Lu
Fuai Lu is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Nuclear Energy and Engineering, having authored 11 papers that have together received 323 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Systemic Lupus Erythematosus Research (4 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Biosimilars and Bioanalytical Methods (1 paper), MicroRNA in disease regulation (1 paper) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Rheumatology (88 citations), Pulmonary and Respiratory Medicine (111 citations), Nephrology (21 citations), Immunology (18 citations) and Molecular Biology (39 citations). Fuai Lu has collaborated with scholars based in China and India. Frequent co-authors include Yongfu Wang, Yuan Liu, Yuan Liu, Le Wang, Yuan Liu, Liu Miao, Le Wang, Fanlei Hu, Ke Li and Le Wang. Their work appears in journals such as BMC Pulmonary Medicine, JAMA Network Open, Clinical Rheumatology, Rheumatology and Therapy and Lupus Science & Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.